Search Results - "Hwan Yang, Deok"

Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma by Yi, Jun Ho, Kim, Seok Jin, Yang, Deok‐Hwan, Do, Young Rok, Won, Jong Ho, Baek, Dongwon, Shin, Ho Jin, Kim, Dae Sik, Kim, Hyo Jung, Kang, Ka‐won, Bae, Sung Hwa, Kwon, Ji‐Hyun, Kwon, Jung Hye, Park, Byeong Bae, Kim, Won Seog

“…Summary The optimal treatment strategy for newly diagnosed primary central nervous system lymphoma (PCNSL) has yet to be established, especially in the…”
Get full text

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma by Song, Ga-Young, Jung, Sung-Hoon, Kim, Kihyun, Kim, Seok Jin, Yoon, Sang Eun, Lee, Ho Sup, Kim, Mihee, Ahn, Seo-Yeon, Ahn, Jae-Sook, Yang, Deok-Hwan, Kim, Hyeoung-Joon, Lee, Je-Jung

“…Recently, the endothelial Activation and Stress Index (EASIX) score has been reported to predict overall survival (OS) after allogeneic stem cell…”
Get full text

Clinical characteristics analysis of sinonasal diffuse large B‐cell lymphoma and extranodal NK/T‐cell lymphoma by Jang, Hye‐Bin, Lee, Dong Hoon, Song, Ga‐Young, Yang, Deok‐Hwan, Lim, Sang Chul

“…Keypoints Extranodal NK/T‐cell lymphoma (ENKL) was the most common sinonasal lymphoma at our hospital. ENKL occurs at a younger age, and is more prevalent in…”
Get full text

Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial by Park, Changhee, Lee, Ho Sup, Kang, Ka-Won, Lee, Won-Sik, Do, Young Rok, Kwak, Jae-Yong, Shin, Ho-Jin, Kim, Sung-Yong, Yi, Jun Ho, Lim, Sung-Nam, Lee, Jeong-Ok, Yang, Deok-Hwan, Jang, Hun, Choi, Byoungsan, Lim, Jiwoo, Sun, Choong Hyun, Byun, Ja Min, Yoon, Sung-Soo, Koh, Youngil

“…Potential synergism between Bruton’s tyrosine kinase (BTK) inhibitor and lenalidomide in treating aggressive B-cell lymphoma has been suggested. Here, the…”
Get full text

Clinical characteristics and prognostic factors of acquired haemophilia A in Korea by Hyun, Shin Young, Shin, Ho‐Jin, Yoon, Sung‐Soo, Moon, Joon Ho, Han, Jae Joon, Yang, Deok‐Hwan, Lee, Won Sik, Bang, Soo‐Mee, Yhim, Ho‐Young, Kim, Sung‐Hyun, Oh, Doyeun, Do, Young Rok, Park, Yong, Choi, Chul Won, Lee, Je‐Hwan, Jang, Ji Eun, Kim, Soo‐Jeong, Hwang, Doh Yu, Kim, Jin Seok

“…Introduction Acquired haemophilia A (AHA) treatment involves the haemostatic treatment for acute haemorrhage and immunosuppressive therapy (IST) to eradicate…”
Get full text

Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era by Baek, Dong Won, Song, Ga-Young, Lee, Ho Sup, Do, Young Rok, Lee, Ji Hyun, Yhim, Ho-Young, Moon, Joon Ho, Yang, Deok-Hwan

“…Elderly patients diagnosed with diffuse large B-cell lymphoma (DLBCL) undergoing reduced intensity R-CHOP therapy are at a heightened risk of acquiring…”
Get full text

A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System by Jung, Sung‐Hoon, Kim, Kihyun, Kim, Jin Seok, Kim, Seok Jin, Cheong, Jung‐Won, Kim, Soo‐Jeoong, Ahn, Jae‐Sook, Ahn, Seo‐Yeon, Yang, Deok‐Hwan, Kim, Hyeoung‐Joon, Lee, Je‐Jung

Get full text

Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model by Thangaraj, Jaya Lakshmi, Ahn, Seo-Yeon, Jung, Sung-Hoon, Vo, Manh-Cuong, Chu, Tan-Huy, Thi Phan, Minh-Trang, Kwon, Minsuk, Lee, Kyung-Hwa, Kim, Mihee, Song, Ga-Young, Yang, Deok-Hwan, Ahn, Jae-Sook, Kim, Hyeoung-Joon, Cho, Duck, Lee, Je-Jung

“…The use of natural killer (NK) cells is a promising and safe immunotherapeutic approach in the field of cancer immunotherapy. However, combination treatments…”
Get full text

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia by Song, Ga-Young, Kim, Hyeon-Jong, Kim, TaeHyung, Ahn, Seo-Yeon, Jung, Sung-Hoon, Kim, Mihee, Yang, Deok-Hwan, Lee, Je-Jung, Kim, Mi Yeon, Cheong, June-Won, Jung, Chul Won, Jang, Jun Ho, Kim, Hee- Je, Moon, Joon Ho, Sohn, Sang Kyun, Won, Jong-Ho, Park, Seong Kyu, Kim, Sung-Hyun, Choi, Chang Kyun, Kim, Hyeoung-Joon, Ahn, Jae-Sook, Kim, Dennis Dong Hwan

“…This study aimed to validate the 2022 European LeukemiaNet (ELN) risk stratification for acute myeloid leukemia (AML). A total of 624 newly diagnosed AML…”
Get full text

Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in de novo diffuse large B-cell lymphoma: a multicenter retrospective study by Kim, Yu Ri, Shin, Ho Jin, Yhim, Ho-Young, Yang, Deok-Hwan, Park, Yong, Lee, Ji Hyun, Lee, Won-Sik, Do, Young Rok, Mun, Yeung-Chul, Kim, Dae Sik, Kim, Jin Seok

“…Bone marrow (BM) involvement is an indicator of a poor prognosis in diffuse large B-cell lymphoma (DLBCL); however, few studies have evaluated the role of…”
Get full text

Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine by Kim, Mihee, Ahn, Seo-Yeon, Kim, TaeHyung, Jung, Sung-Hoon, Song, Ga-Young, Yang, Deok-Hwan, Lee, Je-Jung, Kim, Mi Yeon, Park, Ju Heon, Shin, Myung-Geun, Ahn, Jae-Sook, Kim, Hyeoung-Joon, Kim, Dennis Dong Hwan

“…This study aimed to evaluate the prognostic significance of the revised European LeukemiaNet (ELN)-2022 risk stratification model for 123 elderly acute myeloid…”
Get full text

Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era by Song, Ga-Young, Yoon, Sang Eun, Kim, Seok Jin, Kim, Jin Seok, Koh, Youngil, Moon, Joon-Ho, Oh, Sung Yong, Lee, Ho Sup, Shin, Ho-Jin, Do, Young Rok, Lee, Won Sik, Kim, Dae sik, Park, Yong, Yhim, Ho-Young, Yang, Deok-Hwan

“…There are still controversies about the use of interim positron emission tomography/computed tomography (PET/CT) in indolent non-Hodgkin lymphoma due to the…”
Get full text

Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing by Ahn, Jae-Sook, Kim, TaeHyung, Jung, Sung-Hoon, Ahn, Seo-Yeon, Jung, Seung-Yeon, Song, Ga-Young, Kim, Mihee, Yang, Deok-Hwan, Lee, Je-Jung, Choi, SeungHyun, Lee, Ja-Yeon, Park, Seong-Kyu, Moon, Joon Ho, Lee, Hui Young, Kim, Kyoung Ha, Cai, Yu, Yi, Seong Yoon, Novitzky-Basso, Igor, Zhang, Zhaolei, Kim, Hyeoung-Joon, Kim, Dennis Dong Hwan

“…In patients with acute myeloid leukemia (AML) consolidation treatment options are between allogeneic hematopoietic stem cell transplantation (HCT) and…”
Get full text

Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09) by Kang, Sora, Cho, Hyungwoo, Sohn, Byeong Seok, Oh, Sung Yong, Lee, Won-Sik, Lee, Sang Min, Yang, Deok-Hwan, Huh, Jooryung, Yoon, Dok Hyun, Suh, Cheolwon

“…The standard of treatment for completely resected limited-stage diffuse large B cell lymphoma (DLBCL) in patients without residual lesions has not yet been…”
Get full text

Prediction of immunochemotherapy response for diffuse large B‐cell lymphoma using artificial intelligence digital pathology by Lee, Jeong Hoon, Song, Ga‐Young, Lee, Jonghyun, Kang, Sae‐Ryung, Moon, Kyoung Min, Choi, Yoo‐Duk, Shen, Jeanne, Noh, Myung‐Giun, Yang, Deok‐Hwan

“…Diffuse large B‐cell lymphoma (DLBCL) is a heterogeneous and prevalent subtype of aggressive non‐Hodgkin lymphoma that poses diagnostic and prognostic…”
Get full text

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma by Song, Ga-Young, Jung, Sung-Hoon, Ahn, Seo-Yeon, Jung, Seung-Yeon, Yang, Deok-Hwan, Ahn, Jae-Sook, Kim, Hyeoung-Joon, Lee, Je-Jung

“…For successful autologous stem cell transplantation, the collection of a sufficient number of hematopoietic stem cells after induction therapy is essential for…”
Get full text

Relapse in patients with limited‐stage ocular adnexal lymphoma treated by chemoimmunotherapy: Extended follow‐up of a phase 2 study by Kim, Sung‐Yong, Lee, Won‐Sik, Oh, Sung Yong, Yang, Deok‐Hwan, Kim, Hyo Jung, Park, Seong Kyu, Yang, Jae Wook, Yang, Suk‐Woo, Cho, Seok‐Goo

“…Background Approximately 50% of limited‐stage ocular adnexal mucosa‐associated lymphoid tissue lymphoma (OAML) patients with adverse prognostic factors relapse…”
Get full text

A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy by Vo, Manh-Cuong, Ahn, Seo-Yeon, Chu, Tan-Huy, Uthaman, Saji, Pillarisetti, Shammer, Uong, Tung Nguyen Thanh, Lakshmi, Thangaraj Jaya, Kim, Mihee, Song, Ga-Young, Jung, Sung-Hoon, Yang, Deok-Hwan, Ahn, Jae-Sook, Kim, Hyeoung-Joon, Park, In-Kyu, Lee, Je-Jung

Get full text

Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma by Chu, Tan-Huy, Vo, Manh-Cuong, Lakshmi, Thangaraj Jaya, Ahn, Seo-Yeon, Kim, Mihee, Song, Ga-Young, Yang, Deok-Hwan, Ahn, Jae-Sook, Kim, Hyeoung-Joon, Jung, Sung-Hoon, Lee, Je-Jung

“…•Culture DCs with GM-CSF + IL-4 + IL-15 (IL-15 DCs) can be shortened for 6 days.•IL-15 DCs showed high expression levels of costimulatory receptors, IFN-γ and…”
Get full text

Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study by Yhim, Ho-Young, Park, Yong, Kim, Jeong-A, Shin, Ho-Jin, Do, Young Rok, Moon, Joon Ho, Kim, Min Kyoung, Lee, Won Sik, Kim, Dae Sik, Lee, Myung-Won, Choi, Yoon Seok, Jeong, Seong Hyun, Kim, Kyoung Ha, Kim, Jinhang, Lee, Chang-Hoon, Song, Ga-Young, Yang, Deok-Hwan, Kwak, Jae-Yong

“…Optimal risk stratification based on simplified geriatric assessment to predict treatment-related toxicity and survival needs to be clarified in older patients…”
Get full text